NASDAQConsumer DiscretionaryElectrical Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NVVE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successfully execute M&A and partnerships to expand business | It is pursuing acquisitions to expand its business. | Improving | Failure to complete any meaningful M&A or partnership in next 4 quarters | Qualitative: 2 M&A/partnership agreements signed (Sep-Oct 2026) vs target of >=1 in 4 quarters NVVE entered securities purchase agreements with FirstFire (Sep 2026) and institutional investors (Oct 2026), confirming active M&A/partnership execution. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth and turnaround case, not a proven durable compounder. The long-term thesis is in a watch state: revenue has grown and management is pursuing deals, but recent financial performance remains weak and management execution is volatile.
The valuation model indicates NVVE is cheap versus peers, but confidence in that comparison is low. The expectations gap is negative, while the priced-in label is justified and fragility is low, so the evidence does not point to unusually fragile expectations.
Near term, earnings risk is elevated, with a high estimated chance of another miss, and the company has a run of consecutive misses. Over the multi-year view, revenue growth and lower operating expenses are constructive, but the sharp decline in gross margin and continued cash operating losses leave profitability uncertain.
The thesis depends on revenue growth translating into stronger gross margins and further reduction in cash operating losses. Acquisitions and partnerships remain an active management priority, but recent agreements also include new financial obligations. Sector results and economic growth are additional swing factors, since weaker consumer discretionary momentum or slower GDP growth could add pressure.
Over the next 1 to 3 years, NVVE’s case rests on whether growth and deal activity can lead to better margins and lower losses; current evidence shows progress in some areas but substantial execution and earnings risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 1 supplied quarters. Management reported: “We saw strong year-over-year growth in our CPO business and strengthening of our stationery battery pipeline in Europe, Japan and New Mexico.”” “Megawatts under management in the second quarter increased 5.7% over the fourth quarter of 2025, to 29.9 megawatts from 28.3 megawatts, and an increase of 4.3 or 16.8% compared to the second quarter of 2024.”
Grow revenue to support financial improvement | A primary condition in NUVVE HOLDING CORP's published investment case. The stated target is Revenue grows at least 10% YoY next 4 quarters. | Intact | Revenue growth falls below 10% YoY next 4 quarters | Revenue: $1.227M FY2026-Q2; GAAP. Published target: Revenue grows at least 10% YoY next 4 quarters. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Aug 14, 20261,226,726 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Manage capital and equity financing to support liquidity | A supporting condition in NUVVE HOLDING CORP's published investment case. The stated target is Maintain stable capital structure and avoid new large debt over next year. | Under Pressure | New large debt or equity dilution that worsens financial risk | New debt $280k + equity dilution vs stable capital structure target Company issued $280k convertible note and sold unregistered equity, indicating active dilution and new debt obligations. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Selling, general and administrative expenses were $6.5 million for the three months ended June 30, 2026, compared to $13.9 million for the three months ended June 30, 2025, a decrease of $7.4 million, or 52.9%.” “Net loss was $7.3 million for the three months ended June 30, 2026, compared to $13.6 million for the three months ended June 30, 2025, a decrease of $6.3 million, or 46.2%.” Delivery assessment Nov 4, 2026 |
Reduce operating losses toward financial stability | The company aims to reduce operating losses, which were about -$6.7M in 2025-Q4. | Broken | Operating losses remain worse than -$5M over next 4 quarters | Operating income: $-7.448M FY2026-Q2; GAAP. Published target: Operating loss improves to better than -$5M next 4 quarters. Target period is not explicitly aligned with this observation. Aug 14, 2026-7,448,120 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.